B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

被引:736
作者
Tseng, SY [1 ]
Otsuji, M [1 ]
Gorski, K [1 ]
Huang, X [1 ]
Slansky, JE [1 ]
Pai, SI [1 ]
Shalabi, A [1 ]
Shin, T [1 ]
Pardoll, DM [1 ]
Tsuchiya, H [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA
关键词
dendritic cells; T cell activation; B7; interferon gamma; costimulatory molecule;
D O I
10.1084/jem.193.7.839
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs), unique antigen-presenting cells (APCs) with potent T cell stimulatory capacity, direct the activation and differentiation of T cells by providing costimulatory signals. As such, they are critical regulators of both natural and vaccine-induced immune responses. A new B7 family member, B7-DC, whose expression is highly restricted to DCs, was identified among a library of genes differentially expressed between DCs and activated macrophages. B7-DC fails to bind the B7.1/2 receptors CD28 and cytotoxic T lymphocyte-associated antigen (CTLA)-4, but does bind PD-1, a receptor for B7-H1/PD-L1. B7-DC costimulates T cell proliferation more efficiently than B7.1 and induces a distinct pattern of lymphokine secretion. In particular, B7-DC strongly costimulates interferon gamma but not interleukin (IL)-4 or IL-10 production from isolated naive T cells, These properties of B7-DC may account for some of the unique activity of DCs, such as their ability to initiate potent T helper cell type 1 responses.
引用
收藏
页码:839 / 845
页数:7
相关论文
共 41 条
[1]   T-cell stimulation: an abundance of B7s [J].
Abbas, AK ;
Sharpe, AH .
NATURE MEDICINE, 1999, 5 (12) :1345-1346
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]   B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation [J].
Borriello, F ;
Sethna, MP ;
Boyd, SD ;
Schweitzer, AN ;
Tivol, EA ;
Jacoby, D ;
Strom, TB ;
Simpson, EM ;
Freeman, GJ ;
Sharpe, AH .
IMMUNITY, 1997, 6 (03) :303-313
[4]   Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells [J].
Dhodapkar, MV ;
Steinman, RM ;
Krasovsky, J ;
Munz, C ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :233-238
[5]   ICOS co-stimulatory receptor is essential for T-cell activation and function [J].
Dong, C ;
Juedes, AE ;
Temann, UA ;
Shresta, S ;
Allison, JP ;
Ruddle, NH ;
Flavell, RA .
NATURE, 2001, 409 (6816) :97-101
[6]  
Dong HD, 1999, NAT MED, V5, P1365
[7]   IDENTIFICATION OF RESIDUES IN THE V-DOMAIN OF CD80 (B7-1) IMPLICATED IN FUNCTIONAL INTERACTIONS WITH CD28 AND CTLA4 [J].
FARGEAS, CA ;
TRUNEH, A ;
REDDY, M ;
HURLE, M ;
SWEET, R ;
SEKALY, RP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :667-675
[8]  
FORTIER AH, 1994, ISOLATION MURINE MAC
[9]   REGULATION OF INTERLEUKIN-2 GENE ENHANCER ACTIVITY BY THE T-CELL ACCESSORY MOLECULE CD28 [J].
FRASER, JD ;
IRVING, BA ;
CRABTREE, GR ;
WEISS, A .
SCIENCE, 1991, 251 (4991) :313-316
[10]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034